PPME1
Protein phosphatase methylesterase 1
Also known as: ABDH19, PME-1, PPME1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y570
- Gene
- PPME1
- Ensembl
- ENSG00000214517
- Chromosome
- 11
- Canonical length
- 386 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
This gene encodes a protein phosphatase methylesterase localized to the nucleus. The encoded protein acts on the protein phosphatase-2A catalytic subunit and supports the ERK pathway through dephosphorylation of regulatory proteins. It plays a role in malignant glioma progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]
Canonical amino-acid sequenceUniProt
386 residues, UniProt reviewed canonical sequence.
>Q9Y570|PPME1
1 MSALEKSMHL GRLPSRPPLP GSGGSQSGAK MRMGPGRKRD FSPVPWSQYF ESMEDVEVEN
61 ETGKDTFRVY KSGSEGPVLL LLHGGGHSAL SWAVFTAAII SRVQCRIVAL DLRSHGETKV
121 KNPEDLSAET MAKDVGNVVE AMYGDLPPPI MLIGHSMGGA IAVHTASSNL VPSLLGLCMI
181 DVVEGTAMDA LNSMQNFLRG RPKTFKSLEN AIEWSVKSGQ IRNLESARVS MVGQVKQCEG
241 ITSPEGSKSI VEGIIEEEEE DEEGSESISK RKKEDDMETK KDHPYTWRIE LAKTEKYWDG
301 WFRGLSNLFL SCPIPKLLLL AGVDRLDKDL TIGQMQGKFQ MQVLPQCGHA VHEDAPDKVA
361 EAVATFLIRH RFAEPIGGFQ CVFPGCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PPME1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 59 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 59 nTPM
- cerebral cortex: 40 nTPM
- cerebellum: 35 nTPM
- skeletal muscle: 34 nTPM
- testis: 30 nTPM
- epididymis: 28 nTPM
Single-cell type
- endometrial ciliated cells: 174 nCPM
- erythrocyte progenitors: 150 nCPM
- pancreatic islet cells: 145 nCPM
- gonadotrophs: 140 nCPM
- pituicytes/fscs: 140 nCPM
- myonuclei: 130 nCPM
Immune cell
- NK-cell: 14 nTPM
- memory CD4 T-cell: 13 nTPM
- naive CD4 T-cell: 13 nTPM
- MAIT T-cell: 13 nTPM
- memory CD8 T-cell: 13 nTPM
- plasmacytoid DC: 12 nTPM
Brain region
- cerebral cortex: 59 nTPM
- hypothalamus: 56 nTPM
- pons: 53 nTPM
- hippocampal formation: 52 nTPM
- basal ganglia: 52 nTPM
- midbrain: 46 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.75
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- cadherin binding
- lncRNA binding
- protein kinase binding
- protein phosphatase 2A binding
- protein phosphatase binding
- protein phosphatase inhibitor activity
- protein methylesterase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Alpha/beta hydrolase fold-1
- Alpha/Beta hydrolase fold
- Alpha/beta hydrolase family
- Protein phosphatase methylesterase, eukaryotic
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PPME1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PPME1 as an antibody target. Whether an autoantibody or antibody against PPME1 could matter depends on whether native PPME1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PPME1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PPME1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...